Global Elephantiasis Drug Market Research Report 2021
Table of Contents1 Elephantiasis Drug Market Overview
1.1 Product Overview and Scope of Elephantiasis Drug
1.2 Elephantiasis Drug Segment by Type
1.2.1 Global Elephantiasis Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 EDE-1206
1.2.3 Flubendazole
1.2.4 IIC-942A001
1.2.5 S-0112091
1.2.6 Others
1.3 Elephantiasis Drug Segment by Application
1.3.1 Elephantiasis Drug Sales Comparison by Application: (2021-2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Elephantiasis Drug Market Size Estimates and Forecasts
1.4.1 Global Elephantiasis Drug Revenue 2016-2027
1.4.2 Global Elephantiasis Drug Sales 2016-2027
1.4.3 Elephantiasis Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Elephantiasis Drug Market Competition by Manufacturers
2.1 Global Elephantiasis Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Elephantiasis Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Elephantiasis Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Elephantiasis Drug Manufacturing Sites, Area Served, Product Type
2.5 Elephantiasis Drug Market Competitive Situation and Trends
2.5.1 Elephantiasis Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Elephantiasis Drug Players Market Share by Revenue
2.5.3 Global Elephantiasis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Elephantiasis Drug Retrospective Market Scenario by Region
3.1 Global Elephantiasis Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Elephantiasis Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Elephantiasis Drug Market Facts & Figures by Country
3.3.1 North America Elephantiasis Drug Sales by Country
3.3.2 North America Elephantiasis Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Elephantiasis Drug Market Facts & Figures by Country
3.4.1 Europe Elephantiasis Drug Sales by Country
3.4.2 Europe Elephantiasis Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Elephantiasis Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Elephantiasis Drug Sales by Region
3.5.2 Asia Pacific Elephantiasis Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Elephantiasis Drug Market Facts & Figures by Country
3.6.1 Latin America Elephantiasis Drug Sales by Country
3.6.2 Latin America Elephantiasis Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Elephantiasis Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Elephantiasis Drug Sales by Country
3.7.2 Middle East and Africa Elephantiasis Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Elephantiasis Drug Historic Market Analysis by Type
4.1 Global Elephantiasis Drug Sales Market Share by Type (2016-2021)
4.2 Global Elephantiasis Drug Revenue Market Share by Type (2016-2021)
4.3 Global Elephantiasis Drug Price by Type (2016-2021)
5 Global Elephantiasis Drug Historic Market Analysis by Application
5.1 Global Elephantiasis Drug Sales Market Share by Application (2016-2021)
5.2 Global Elephantiasis Drug Revenue Market Share by Application (2016-2021)
5.3 Global Elephantiasis Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Elephantiasis Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Johnson & Johnson Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Anacor Pharmaceuticals, Inc.
6.2.1 Anacor Pharmaceuticals, Inc. Corporation Information
6.2.2 Anacor Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Anacor Pharmaceuticals, Inc. Elephantiasis Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Anacor Pharmaceuticals, Inc. Product Portfolio
6.2.5 Anacor Pharmaceuticals, Inc. Recent Developments/Updates
6.3 AbbVie Inc
6.3.1 AbbVie Inc Corporation Information
6.3.2 AbbVie Inc Description and Business Overview
6.3.3 AbbVie Inc Elephantiasis Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 AbbVie Inc Product Portfolio
6.3.5 AbbVie Inc Recent Developments/Updates
6.4 Eisai Co Ltd
6.4.1 Eisai Co Ltd Corporation Information
6.4.2 Eisai Co Ltd Description and Business Overview
6.4.3 Eisai Co Ltd Elephantiasis Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eisai Co Ltd Product Portfolio
6.4.5 Eisai Co Ltd Recent Developments/Updates
7 Elephantiasis Drug Manufacturing Cost Analysis
7.1 Elephantiasis Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Elephantiasis Drug
7.4 Elephantiasis Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Elephantiasis Drug Distributors List
8.3 Elephantiasis Drug Customers
9 Elephantiasis Drug Market Dynamics
9.1 Elephantiasis Drug Industry Trends
9.2 Elephantiasis Drug Growth Drivers
9.3 Elephantiasis Drug Market Challenges
9.4 Elephantiasis Drug Market Restraints
10 Global Market Forecast
10.1 Elephantiasis Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Elephantiasis Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Elephantiasis Drug by Type (2022-2027)
10.2 Elephantiasis Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Elephantiasis Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Elephantiasis Drug by Application (2022-2027)
10.3 Elephantiasis Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Elephantiasis Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Elephantiasis Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Elephantiasis Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Elephantiasis Drug Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Elephantiasis Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Elephantiasis Drug Covered in This Study
Table 5. Global Elephantiasis Drug Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Elephantiasis Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Elephantiasis Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Elephantiasis Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Elephantiasis Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Elephantiasis Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Elephantiasis Drug Product Type
Table 12. Global Elephantiasis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Elephantiasis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Elephantiasis Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Elephantiasis Drug Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Elephantiasis Drug Sales Market Share by Region (2016-2021)
Table 17. Global Elephantiasis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Elephantiasis Drug Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Elephantiasis Drug Sales Market Share by Country (2016-2021)
Table 20. North America Elephantiasis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Elephantiasis Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Elephantiasis Drug Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Elephantiasis Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Elephantiasis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Elephantiasis Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Elephantiasis Drug Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Elephantiasis Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Elephantiasis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Elephantiasis Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Elephantiasis Drug Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Elephantiasis Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Elephantiasis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Elephantiasis Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Elephantiasis Drug Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Elephantiasis Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Elephantiasis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Elephantiasis Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Elephantiasis Drug Sales (K Pcs) by Type (2016-2021)
Table 39. Global Elephantiasis Drug Sales Market Share by Type (2016-2021)
Table 40. Global Elephantiasis Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Elephantiasis Drug Revenue Share by Type (2016-2021)
Table 42. Global Elephantiasis Drug Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Elephantiasis Drug Sales (K Pcs) by Application (2016-2021)
Table 44. Global Elephantiasis Drug Sales Market Share by Application (2016-2021)
Table 45. Global Elephantiasis Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Elephantiasis Drug Revenue Share by Application (2016-2021)
Table 47. Global Elephantiasis Drug Price (USD/Pcs) by Application (2016-2021)
Table 48. Johnson & Johnson Corporation Information
Table 49. Johnson & Johnson Description and Business Overview
Table 50. Johnson & Johnson Elephantiasis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Johnson & Johnson Elephantiasis Drug Product
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Anacor Pharmaceuticals, Inc. Corporation Information
Table 54. Anacor Pharmaceuticals, Inc. Description and Business Overview
Table 55. Anacor Pharmaceuticals, Inc. Elephantiasis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Anacor Pharmaceuticals, Inc. Elephantiasis Drug Product
Table 57. Anacor Pharmaceuticals, Inc. Recent Developments/Updates
Table 58. AbbVie Inc Corporation Information
Table 59. AbbVie Inc Description and Business Overview
Table 60. AbbVie Inc Elephantiasis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. AbbVie Inc Elephantiasis Drug Product
Table 62. AbbVie Inc Recent Developments/Updates
Table 63. Eisai Co Ltd Corporation Information
Table 64. Eisai Co Ltd Description and Business Overview
Table 65. Eisai Co Ltd Elephantiasis Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Eisai Co Ltd Elephantiasis Drug Product
Table 67. Eisai Co Ltd Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Elephantiasis Drug Distributors List
Table 71. Elephantiasis Drug Customers List
Table 72. Elephantiasis Drug Market Trends
Table 73. Elephantiasis Drug Growth Drivers
Table 74. Elephantiasis Drug Market Restraints
Table 75. Global Elephantiasis Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 76. Global Elephantiasis Drug Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Elephantiasis Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Elephantiasis Drug Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Elephantiasis Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 80. Global Elephantiasis Drug Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Elephantiasis Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Elephantiasis Drug Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Elephantiasis Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 84. Global Elephantiasis Drug Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Elephantiasis Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Elephantiasis Drug Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Elephantiasis Drug
Figure 2. Global Elephantiasis Drug Market Share by Type in 2020 & 2027
Figure 3. EDE-1206 Product Picture
Figure 4. Flubendazole Product Picture
Figure 5. IIC-942A001 Product Picture
Figure 6. S-0112091 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Elephantiasis Drug Market Share by Application in 2020 & 2027
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Elephantiasis Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Elephantiasis Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Elephantiasis Drug Sales 2016-2027 (K Pcs)
Figure 15. Global Elephantiasis Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Elephantiasis Drug Sales Share by Manufacturers in 2020
Figure 17. Global Elephantiasis Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Elephantiasis Drug Players: Market Share by Revenue in 2020
Figure 19. Elephantiasis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Elephantiasis Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Elephantiasis Drug Sales Market Share by Region in 2020
Figure 22. Global Elephantiasis Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Elephantiasis Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Elephantiasis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Elephantiasis Drug by Type (2016-2021)
Figure 49. Sales Market Share of Elephantiasis Drug by Application (2016-2021)
Figure 50. Sales Market Share of Elephantiasis Drug by Application in 2020
Figure 51. Revenue Share of Elephantiasis Drug by Application (2016-2021)
Figure 52. Revenue Share of Elephantiasis Drug by Application in 2020
Figure 53. Manufacturing Cost Structure of Elephantiasis Drug
Figure 54. Manufacturing Process Analysis of Elephantiasis Drug
Figure 55. Elephantiasis Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed